7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Carcinoma D002277 18 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Carcinoma, Papillary D002291 3 associated lipids
Carcinosarcoma D002296 7 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Celiac Disease D002446 16 associated lipids
Brain Ischemia D002545 89 associated lipids
Cherubism D002636 1 associated lipids
Chondroblastoma D002804 1 associated lipids
Chondrocalcinosis D002805 1 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Li G et al. Curcumin improves bone microarchitecture in glucocorticoid-induced secondary osteoporosis mice through the activation of microRNA-365 via regulating MMP-9. 2015 Int J Clin Exp Pathol pmid:26884838
Li B et al. Expression of OPG, RANKL, and RUNX2 in rabbit periodontium under orthodontic force. 2015 Genet. Mol. Res. pmid:26782591
Mrozikiewicz-Rakowska B et al. Genetic and environmental predictors of chronic kidney disease in patients with type 2 diabetes and diabetic foot ulcer: a pilot study. 2015 J. Physiol. Pharmacol. pmid:26579581
Kurz K et al. Effects of Antitumor Necrosis Factor Therapy on Osteoprotegerin, Neopterin, and sRANKL Concentrations in Patients with Rheumatoid Arthritis. 2015 Dis. Markers pmid:26576067
Liu W et al. Osteoprotegerin Induces Apoptosis of Osteoclasts and Osteoclast Precursor Cells via the Fas/Fas Ligand Pathway. 2015 PLoS ONE pmid:26571489
Schiro A et al. Elevated levels of endothelial-derived microparticles, and serum CXCL9 and SCGF-β are associated with unstable asymptomatic carotid plaques. 2015 Sci Rep pmid:26564003
Mizuno M et al. Reveromycin A Administration Prevents Alveolar Bone Loss in Osteoprotegerin Knockout Mice with Periodontal Disease. 2015 Sci Rep pmid:26561427
Morisawa T et al. Osteoprotegerin is Associated With Endothelial Function and Predicts Early Carotid Atherosclerosis in Patients With Coronary Artery Disease. 2015 Int Heart J pmid:26549398
Beuselinck B et al. RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs. 2015 Br. J. Cancer pmid:26528707
Rewiuk K and Grodzicki T Osteoprotegerin and TRAIL in Acute Onset of Atrial Fibrillation. 2015 Biomed Res Int pmid:26504794
Pesce Viglietti AI et al. Brucella abortus Invasion of Osteocytes Modulates Connexin 43 and Integrin Expression and Induces Osteoclastogenesis via Receptor Activator of NF-κB Ligand and Tumor Necrosis Factor Alpha Secretion. 2015 Infect. Immun. pmid:26459511
Nemeth ZK et al. Serum osteoprotegerin is associated with pulse pressure in kidney transplant recipients. 2015 Sci Rep pmid:26459001
Grosjean F et al. Dendritic Cells Cause Bone Lesions in a New Mouse Model of Histiocytosis. 2015 PLoS ONE pmid:26247358
Lewis JR et al. Elevated Circulating Osteoprotegerin and Renal Dysfunction Predict 15-Year Cardiovascular and All-Cause Mortality: A Prospective Study of Elderly Women. 2015 PLoS ONE pmid:26222774
Audo R et al. Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort. 2015 Arthritis Res. Ther. pmid:26220665
Wang J et al. RANKL and OPG Polymorphisms Are Associated with Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients. 2015 PLoS ONE pmid:26218592
Kao SY and Stankovic KM Transactivation of human osteoprotegerin promoter by GATA-3. 2015 Sci Rep pmid:26216189
Kassem A et al. TLR5, a novel mediator of innate immunity-induced osteoclastogenesis and bone loss. 2015 FASEB J. pmid:26207027
Yang H et al. A novel model of bisphosphonate-related osteonecrosis of the jaw in rats. 2015 Int J Clin Exp Pathol pmid:26191212
Pitari MR et al. Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts. 2015 Oncotarget pmid:26160841
Hsu BG et al. High Serum Osteoprotegerin Is Associated with Arterial Stiffness in Kidney Transplant Patients. 2015 Tohoku J. Exp. Med. pmid:26156285
Miao X et al. Nanosecond pulsed electric field inhibits proliferation and induces apoptosis in human osteosarcoma. 2015 J Orthop Surg Res pmid:26148858
Bartosińska J et al. The Assessment of Selected Bone and Cartilage Biomarkers in Psoriatic Patients from Poland. 2015 Mediators Inflamm. pmid:26146462
Ye M et al. Prednisone inhibits the focal adhesion kinase/receptor activator of NF-κB ligand/mitogen-activated protein kinase signaling pathway in rats with adriamycin-induced nephropathy. 2015 Mol Med Rep pmid:26459042
Priyadarshi S et al. Genetic association and altered gene expression of osteoprotegerin in otosclerosis patients. 2015 Ann. Hum. Genet. pmid:25998045
Yang Y et al. The Proteasome Inhibitor Carfilzomib Suppresses Parathyroid Hormone-induced Osteoclastogenesis through a RANKL-mediated Signaling Pathway. 2015 J. Biol. Chem. pmid:25979341
Ehlken C et al. Increased expression of angiogenic and inflammatory proteins in the vitreous of patients with ischemic central retinal vein occlusion. 2015 PLoS ONE pmid:25978399
Ardeshirpour L et al. OPG Treatment Prevents Bone Loss During Lactation But Does Not Affect Milk Production or Maternal Calcium Metabolism. 2015 Endocrinology pmid:25961842
Reveille JD Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis. 2015 Clin. Rheumatol. pmid:25939520
Bortolin RH et al. Protection against T1DM-Induced Bone Loss by Zinc Supplementation: Biomechanical, Histomorphometric, and Molecular Analyses in STZ-Induced Diabetic Rats. 2015 PLoS ONE pmid:25933189
Wei J et al. Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats. 2015 Mol Med Rep pmid:25891179
Su F et al. Enhancement of periodontal tissue regeneration by transplantation of osteoprotegerin-engineered periodontal ligament stem cells. 2015 Stem Cell Res Ther pmid:25888745
Shen Y et al. (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway. 2015 BMC Complement Altern Med pmid:25887296
Duan P et al. Gene polymorphisms in RANKL/RANK/OPG pathway are associated with ages at menarche and natural menopause in Chinese women. 2015 BMC Womens Health pmid:25884698
Warren JT et al. Correlating RANK ligand/RANK binding kinetics with osteoclast formation and function. 2015 J. Cell. Biochem. pmid:25864714
HaDuong JH et al. Interaction between bone marrow stromal cells and neuroblastoma cells leads to a VEGFA-mediated osteoblastogenesis. 2015 Int. J. Cancer pmid:25648303
Higgs JT et al. Variants of Osteoprotegerin Lacking TRAIL Binding for Therapeutic Bone Remodeling in Osteolytic Malignancies. 2015 Mol. Cancer Res. pmid:25636966
Lanza D et al. Impact of the uremic milieu on the osteogenic potential of mesenchymal stem cells. 2015 PLoS ONE pmid:25635832
Dale MD et al. Bone-remodeling transcript levels are independent of perching in end-of-lay white leghorn chickens. 2015 Int J Mol Sci pmid:25625518
Ottewell PD et al. OPG-Fc inhibits ovariectomy-induced growth of disseminated breast cancer cells in bone. 2015 Int. J. Cancer pmid:25603921
Son GY et al. Hypotonic stress induces RANKL via transient receptor potential melastatin 3 (TRPM3) and vaniloid 4 (TRPV4) in human PDL cells. 2015 J. Dent. Res. pmid:25595364
Oostra DR et al. Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. 2015 Mol. Cell. Endocrinol. pmid:25575458
Majerczyk M et al. [Osteoprotegerin as a marker of atherosclerosis and a prognostic factor in stroke]. 2015 Postepy Hig Med Dosw (Online) pmid:27259222
Fu Y et al. Involvement of the Ca²⁺ signaling pathway in osteoprotegerin inhibition of osteoclast differentiation and maturation. 2015 J. Vet. Sci. pmid:25549213
Recker EN et al. A cross-sectional assessment of biomarker levels around implants versus natural teeth in periodontal maintenance patients. 2015 J. Periodontol. pmid:25269523
Hung JY et al. Tricetin, a dietary flavonoid, suppresses benzo(a)pyrene‑induced human non‑small cell lung cancer bone metastasis. 2015 Int. J. Oncol. pmid:25738754
Nash LA et al. Rooibos flavonoids, orientin and luteolin, stimulate mineralization in human osteoblasts through the Wnt pathway. 2015 Mol Nutr Food Res pmid:25488131
Jin Y et al. Functional role of mechanosensitive ion channel Piezo1 in human periodontal ligament cells. 2015 Angle Orthod pmid:24810489
Kelesidis T et al. Role of RANKL-RANK/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection. 2014 Jul-Sep AIDS Rev pmid:25102334
Bastos MF et al. Impact of caffeine and/or estrogen deficiency on trabecular bone area and healing: a study in rats. 2014 Jan-Feb Int J Oral Maxillofac Implants pmid:24451874
Sagar DR et al. Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis. 2014 Ann. Rheum. Dis. pmid:23723320
Liu M et al. Curculigoside improves osteogenesis of human amniotic fluid-derived stem cells. 2014 Stem Cells Dev. pmid:24007307
Guo L et al. Association between seven common OPG genetic polymorphisms and osteoporosis risk: a meta-analysis. 2014 DNA Cell Biol. pmid:24283361
Miller RE et al. RANKL inhibition blocks osteolytic lesions and reduces skeletal tumor burden in models of non-small-cell lung cancer bone metastases. 2014 J Thorac Oncol pmid:24496001
Lim WH et al. Downregulation of Wnt causes root resorption. 2014 Am J Orthod Dentofacial Orthop pmid:25172256
Shen A et al. Role of osteoprotegerin and its gene polymorphisms in the occurrence of left ventricular hypertrophy in essential hypertensive patients. 2014 Medicine (Baltimore) pmid:25546658
MacMillan AK et al. Similar healthy osteoclast and osteoblast activity on nanocrystalline hydroxyapatite and nanoparticles of tri-calcium phosphate compared to natural bone. 2014 Int J Nanomedicine pmid:25506216
Jiang Y et al. Achyranthes bidentata extract exerts osteoprotective effects on steroid-induced osteonecrosis of the femoral head in rats by regulating RANKL/RANK/OPG signaling. 2014 J Transl Med pmid:25471933
Akiyama T et al. Porphyromonas gingivalis-derived lysine gingipain enhances osteoclast differentiation induced by tumor necrosis factor-α and interleukin-1β but suppresses that by interleukin-17A: importance of proteolytic degradation of osteoprotegerin by lysine gingipain. 2014 J. Biol. Chem. pmid:24755218
Titanji K et al. Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection. 2014 PLoS Pathog. pmid:25393853
Akiyama N et al. Limitation of immune tolerance-inducing thymic epithelial cell development by Spi-B-mediated negative feedback regulation. 2014 J. Exp. Med. pmid:25385757
Lv Y et al. Effects of pamidronate disodium on the loss of osteoarthritic subchondral bone and the expression of cartilaginous and subchondral osteoprotegerin and RANKL in rabbits. 2014 BMC Musculoskelet Disord pmid:25377946
D'Abramo A et al. Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis. 2014 Mediators Inflamm. pmid:25374442
Samir SM and Malek HA Effect of cannabinoid receptors 1 modulation on osteoporosis in a rat model of different ages. 2014 J. Physiol. Pharmacol. pmid:25371528
Zhang X et al. Ultrastructural characterization of the implant interface response to loading. 2014 J. Dent. Res. pmid:24389808
Lv Z et al. Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/β-catenin pathway. 2014 Oncol. Rep. pmid:24337584
Kim JY et al. (2S)-2'-Methoxykurarinone inhibits osteoclastogenesis and bone resorption through down-regulation of RANKL signaling. 2014 Biol. Pharm. Bull. pmid:24492722
Hayashida C et al. Osteocytes produce interferon-β as a negative regulator of osteoclastogenesis. 2014 J. Biol. Chem. pmid:24610813
Callegari A et al. Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6. 2014 J. Vasc. Res. pmid:24642764
Köttstorfer J et al. Are OPG and RANKL involved in human fracture healing? 2014 J. Orthop. Res. pmid:25212894
Esteghamati A et al. Serum osteoprotegerin in relation to metabolic status, severity, and estimated risk of subsequent coronary heart disease. 2014 Arch Iran Med pmid:25204474
Jasiewicz M et al. Potential pathogenic role of soluble receptor activator of nuclear factor-ĸB ligand and osteoprotegerin in patients with pulmonary arterial hypertension. 2014 Pol. Arch. Med. Wewn. pmid:25188298
Genre F et al. Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis. 2014 PLoS ONE pmid:25184828
Zhang YD et al. Association of the g.19074G>A genetic variant in the osteoprotegerin gene with bone mineral density in Chinese postmenopausal women. 2014 Genet. Mol. Res. pmid:25177945
Bandeira F et al. Bone markers and osteoporosis therapy. 2014 Arq Bras Endocrinol Metabol pmid:25166041
Foo JP et al. The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea. 2014 J. Clin. Endocrinol. Metab. pmid:25148234
Kuroyanagi G et al. Resveratrol suppresses prostaglandin F(2α)-induced osteoprotegerin synthesis in osteoblasts: inhibition of the MAP kinase signaling. 2014 Arch. Biochem. Biophys. pmid:24333336
Warren JT et al. Manipulation of receptor oligomerization as a strategy to inhibit signaling by TNF superfamily members. 2014 Sci Signal pmid:25140055
Jung Koo H et al. Effect of the combinatory mixture of Rubus coreanus Miquel and Astragalus membranaceus Bunge extracts on ovariectomy-induced osteoporosis in mice and anti-RANK signaling effect. 2014 J Ethnopharmacol pmid:24333364
Yan D et al. Serum levels of M-CSF, RANKL and OPG in rats fed with Kashin-Beck disease-affected diet. 2014 J Orthop Surg Res pmid:25138985
Schieferdecker A et al. Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKL. 2014 Oncotarget pmid:25138051
Bosman MC et al. Decreased affinity of recombinant human tumor necrosis factor-related apoptosis-inducing ligand (rhTRAIL) D269H/E195R to osteoprotegerin (OPG) overcomes TRAIL resistance mediated by the bone microenvironment. 2014 J. Biol. Chem. pmid:24280212
Chung SL et al. Low-magnitude high-frequency vibration enhances gene expression related to callus formation, mineralization and remodeling during osteoporotic fracture healing in rats. 2014 J. Orthop. Res. pmid:25131218
Kim YH et al. Enhancement of bone regeneration by dual release of a macrophage recruitment agent and platelet-rich plasma from gelatin hydrogels. 2014 Biomaterials pmid:24125774
Ohlsson C et al. Probiotics protect mice from ovariectomy-induced cortical bone loss. 2014 PLoS ONE pmid:24637895
Araújo AA et al. Azilsartan increases levels of IL-10, down-regulates MMP-2, MMP-9, RANKL/RANK, Cathepsin K and up-regulates OPG in an experimental periodontitis model. 2014 PLoS ONE pmid:24819928
Cianciolo G et al. Importance of vascular calcification in kidney transplant recipients. 2014 Am. J. Nephrol. pmid:24819032
Sänger N et al. OPG and PgR show similar cohort specific effects as prognostic factors in ER positive breast cancer. 2014 Mol Oncol pmid:24785095
Hidayat R et al. Correlation between receptor activator of nuclear factor-κβ ligand (RANKL), and osteoprotegerin (OPG) with cartilage degradation in rheumatoid arthritis patients. 2014 Acta Med Indones pmid:24760805
Milanova V et al. TLR2 elicits IL-17-mediated RANKL expression, IL-17, and OPG production in neutrophils from arthritic mice. 2014 Mediators Inflamm. pmid:24757287
Nolen BM et al. Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study. 2014 PLoS ONE pmid:24747429
Zhao JJ et al. Association analysis between the OPG g.27667T>A genetic variant and bone mineral density in Chinese postmenopausal women. 2014 Genet. Mol. Res. pmid:24737508
Yoo YM et al. Effects of neuropeptides and mechanical loading on bone cell resorption in vitro. 2014 Int J Mol Sci pmid:24717410
Deng L et al. Tissue distribution of emulsified γ-tocotrienol and its long-term biological effects after subcutaneous administration. 2014 Lipids Health Dis pmid:24712339
Chung PL et al. Effect of age on regulation of human osteoclast differentiation. 2014 J. Cell. Biochem. pmid:24700654
Shao X et al. Metformin rescues the MG63 osteoblasts against the effect of high glucose on proliferation. 2014 J Diabetes Res pmid:24812633
Sirjani M et al. The effects of high fat, low carbohydrate and low fat, high carbohydrate diets on tumor necrosis factor superfamily proteins and proinflammatory cytokines in C57BL/6 mice. 2014 Iran J Allergy Asthma Immunol pmid:24659160
Wang JH et al. Association of serum osteoprotegerin levels with carotid-femoral pulse wave velocity in hypertensive patients. 2014 J Clin Hypertens (Greenwich) pmid:24640954
Guo L et al. Effects of erythropoietin on osteoblast proliferation and function. 2014 Clin. Exp. Med. pmid:23135151
Navratilova Z et al. Osteoprotegerin gene polymorphism is not associated with prosthetic joint infection after total joint arthroplasty in the Czech population. 2014 Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub pmid:22660233

Table of Content